These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

226 related articles for article (PubMed ID: 4593132)

  • 1. Rifampin therapy of pulmonary tuberculosis in patients not treated previously with antituberculous drugs.
    Eidus L; Jessamine AG; Helbaque DM; Narasimhan V
    Int J Clin Pharmacol; 1974 Jan; 9(1):81-6. PubMed ID: 4593132
    [No Abstract]   [Full Text] [Related]  

  • 2. [Treatment of tuberculosis with streptomycin and isoniazide combined with either aminosalyl or rifampicin].
    Engbaek HC; Larsen SO; Rasmussen KN; Vergmann B
    Ugeskr Laeger; 1973 Aug; 135(34):1795-9. PubMed ID: 4592618
    [No Abstract]   [Full Text] [Related]  

  • 3. [Analytic study of 80 cases of pulmonary tuberculosis treated with the INH-STRE-PAS regime during 1971-2].
    Chabbou A; Maalej M; Zbiba M; El Gharbi T; El Mekki L; Chebbi ML; Djenayah F; Ben Salah M; El Gharbi B; Jeguirim M; Cherif M
    Tunis Med; 1974; 52(6):305-11. PubMed ID: 4619936
    [No Abstract]   [Full Text] [Related]  

  • 4. [Clinical evaluation of Rifampicin in pulmonary tuberculosis. 2. A controlled trial on the clinical effects of chemotherapy with Rifampicin-INH-PAS and SM-INH-PAS for treatment of original cases of pulmonary tuberculosis].
    Donomae I; Fujita S; Gomi J; Hibino S; Horai Z
    Kekkaku; 1970 Aug; 45(8):257-62. PubMed ID: 4918166
    [No Abstract]   [Full Text] [Related]  

  • 5. [Clinical effects of rifampicin for pulmonary tuberculosis patients. 1. Comparison of rifampicin-ethambutol-isoniazid with streptomycin-paraminosalcylic acid-isoniazid in the original treatment of pulmonary tuberculosis patients].
    Kekkaku; 1971 Oct; 46(10):393-9. PubMed ID: 5147895
    [No Abstract]   [Full Text] [Related]  

  • 6. [Comparison of three regimens, INH-SM-PAS, INH-SM-RFP and INH-PAS-RFP, in the original treatment cases of pulmonary tuberculosis. Report of the 13th series study (original treatment study)].
    Kekkaku; 1973 Jun; 48(6):235-45. PubMed ID: 4581528
    [No Abstract]   [Full Text] [Related]  

  • 7. [Drug therapy of pulmonary tuberculosis].
    Ludes H
    Dtsch Med Wochenschr; 1972 Feb; 97(8):289-91. PubMed ID: 5058425
    [No Abstract]   [Full Text] [Related]  

  • 8. [Changes in the bacteriologic findings in patients treated with rifomycin, alone or associated with other drugs].
    Delli Veneri F; Centrella G; Stefanelli R
    Arch Tisiol Mal Appar Respir; 1968 May; 23(5):387-98. PubMed ID: 4979475
    [No Abstract]   [Full Text] [Related]  

  • 9. [Modern tuberculosis therapy].
    Krohn J
    Tidsskr Nor Laegeforen; 1973 Dec; 93(35):2576-8. PubMed ID: 4772808
    [No Abstract]   [Full Text] [Related]  

  • 10. Interaction aspects of antimycobacterial drugs in the chemotherapy of tuberculosis. I. Role of individual antituberculous drugs in drug regimens used in the chemotherapy of human tuberculosis.
    Trnka L; Tousek J
    Chemotherapy; 1974; 20(3):165-76. PubMed ID: 4136827
    [No Abstract]   [Full Text] [Related]  

  • 11. Serum enzyme changes in patients receiving antituberculosis therapy with rifampicin or p-aminosalicylic acid, plus isoniazid and streptomycin.
    Baron DN; Bell JL
    Tubercle; 1974 Jun; 55(2):115-20. PubMed ID: 4620296
    [No Abstract]   [Full Text] [Related]  

  • 12. [Rifampicin in the treatment of lung and kidney tuberculosis].
    Kraan JK; Mulder RJ; Mulder-De Jong MT; van Dijk B
    Ned Tijdschr Geneeskd; 1972 Jan; 116(1):9-15. PubMed ID: 4555064
    [No Abstract]   [Full Text] [Related]  

  • 13. [Treatment of pulmonary tuberculosis in developing countries].
    Larbaoui D
    Tunis Med; 1974; 52(2):59-66. PubMed ID: 4140601
    [No Abstract]   [Full Text] [Related]  

  • 14. [Proceedings: Significance and limits of controlled clinical research (in pulmonary tuberculosis)].
    Bignall JR
    Z Erkr Atmungsorgane Folia Bronchol; 1973; 138(1):103-6. PubMed ID: 4588016
    [No Abstract]   [Full Text] [Related]  

  • 15. [Progress in the treatment of tuberculosis. Isoniazid plus rifomycin plus myambutol equals standard therapy].
    Freerksen E
    Dtsch Med Wochenschr; 1970 Jan; 95(3):139-41. PubMed ID: 5411222
    [No Abstract]   [Full Text] [Related]  

  • 16. [The course of pulmonary tuberculosis in the initial phase of various intensive therapy combinations].
    Kindler U; Derichs R; Merholz S
    Med Welt; 1976 Feb; 27(8):387-8. PubMed ID: 1256307
    [No Abstract]   [Full Text] [Related]  

  • 17. Primary resistance to major antituberculous drugs in patients with pulmonary tuberculosis in the years 1957-1964.
    Polończyk M
    Pol Med J; 1967; 6(3):604-9. PubMed ID: 6038083
    [No Abstract]   [Full Text] [Related]  

  • 18. [Reduction of fresh forms of pulmonary tuberculosis by the classical treatment and by combined antibiotics including rifampicin (comparative study of a personal survey)].
    Weill G; Lévy A; Guignon JP; Lecoq H; Friess JM; Maman P
    Rev Tuberc Pneumol (Paris); 1969 Dec; 33(8):1119-25. PubMed ID: 4916253
    [No Abstract]   [Full Text] [Related]  

  • 19. [Five year follow-up study on the short-course chemotherapy for pulmonary tuberculosis in Niigata Prefecture].
    Hashimoto T; Shimao T; Aoki M; Misawa H; Takasawa N; Shiozawa S
    Kekkaku; 1984 Jun; 59(6):369-76. PubMed ID: 6492547
    [No Abstract]   [Full Text] [Related]  

  • 20. Rifampicin plus isoniazid, rifampicin plus PAS, and isoniazid plus PAS in the initial treatment of pulmonary tuberculosis. A controlled multicenter clinical trial.
    Tousek J; Votruba R
    Chemotherapy; 1974; 20(3):183-200. PubMed ID: 4605071
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.